We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Obituary |

Ellsworth (Buster) Alvord, MD (1923-2010) FREE

Olaf Stüve, MD, PhD
[+] Author Affiliations

Author Affiliation: Neurology Section, Veterans Affairs North Texas Health Care System, Medical Service, Dallas, Texas.

Arch Neurol. 2010;67(6):774. doi:10.1001/archneurol.2010.112.
Text Size: A A A
Published online

Ellsworth (Buster) Alvord was a neuropathologist whose work and personality has inspired many neurologists during the past 6 decades. A native of Washington, DC, he received his Bachelor of Science from Haverford College in 1943, followed by a medical degree from Cornell University Medical College 3 years later. He then completed residency training in neurology and pathology at New York Hospital and Walter Reed Hospital. Dr Alvord later conducted neuroimmunology research at the National Institute of Neurological Disorders and Stroke in Washington, DC, before joining Baylor Medical College in Houston as faculty in neuropathology. In 1960, he became the Chief of Neuropathology at the University of Washington School of Medicine, where he continued to work and conduct research until his death.

Place holder to copy figure label and caption

Ellsworth Alvord, MD

Graphic Jump Location

Discoveries during the early part of his medical education must have inspired Dr Alvord's research career. It was shortly after Thomas Rivers, MD, developed the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis that a viral model of murine central nervous system disease caused by the neurotropic ribonucleic acid Theiler murine encephalomyelitis virus was first described. Both models were quickly recognized as having immunological and histopathological resemblance to multiple sclerosis, and both have since been used to study the underlying mechanisms of human inflammatory demyelinating disorders. It must have been an exciting time for an aspiring and hard-working neuroimmunologist.

The list of Dr Alvord's contributions to the field is impressive, and he had the ability to identify relevant research questions. In fact, many of the topics that caught his intellectual curiosity are again the focus of research for a new generation of investigators. In 1948, he published an article on the distribution of central nervous system autoantigen in EAE in the guinea pig. For the next 30 years, he mapped dominant determinants of myelin antigens in several species. He and his colleagues also identified the potential of myelin as a treatment of central nervous system autoimmune disease, an observation that was tested decades later in clinical studies. Together with other investigators from the Pacific Northwest (Don Paty, MD, included), Dr Alvord detected paraclinical disease activity in animals with EAE by magnetic resonance imaging in 1985. While he was one of the first to express caution regarding the limitations associated with the EAE model when studying multiple sclerosis, he was also one of the first to test antibodies against monospecific targets as therapy. In 1987, Dr Alvord and colleagues recognized the importance of age of infections in childhood in determining the risk of multiple sclerosis. In the same year, he studied the role of B cells in EAE, a cell type that had largely been ignored in this context.

In the last 2 decades of his life, Dr Alvord's research focused almost exclusively on gliomas, specifically on models that would allow the prediction of clinical and paraclinical outcomes. I suspect that this shift in scientific interest was mainly driven by the patients he was responsible for as a neuropathologist at the University of Washington. After the introduction of magnetic resonance imaging to clinical neurological practice, the requirements for frequent biopsies in patients with multiple sclerosis and related disorders no longer existed.

Teaching neuropathology to medical students, residents, and pathology fellows was another passion of Dr Alvord’s. A number of his former protégés became academic leaders in the field. Dr Alvord published on his teaching experience in neuropathology at the University of Washington in medical journals. He and his family have also been generous supporters of medical, scientific, and cultural causes in Seattle and other parts of the country.

I had the opportunity to be acquainted with Dr Alvord when I was a neurology resident at the University of Washington, and I can attest to the fact that he was an impressive man and physician. If I have one regret about my residency, it is that I should have spend more time with Dr Alvord and listened to his views on neuroinflammation and autoimmunity of the central nervous system. He will be greatly missed by many.


Correspondence: Dr Stüve, Neurology Section, Veterans Affairs North Texas Health Care System, Medical Service, 4500 S Lancaster Rd, Dallas, TX 75216 (olaf.stuve@utsouthwestern.edu).

Financial Disclosure: None reported.


Place holder to copy figure label and caption

Ellsworth Alvord, MD

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Does This Patient Have a Torn Meniscus or Ligament of the Knee?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis